Advertisement
Review Article| Volume 92, P206-216, March 2019

Download started.

Ok

Surgical management of obesity

  • Jacob Nudel
    Affiliations
    Department of Surgery, Boston University School of Medicine, Boston, MA, United States of America

    Institute for Health System Innovation and Policy, Boston University, Boston, MA, United States of America
    Search for articles by this author
  • Vivian M. Sanchez
    Correspondence
    Corresponding author at: Department of Surgery, Boston University School of Medicine, 1400 VFW Pkwy, SS112, West Roxbury, MA 02132, United States of America.
    Affiliations
    Department of Surgery, Boston University School of Medicine, Boston, MA, United States of America

    Department of Surgery, VA Boston Healthcare System, Boston, MA, United States of America
    Search for articles by this author
Published:December 18, 2018DOI:https://doi.org/10.1016/j.metabol.2018.12.002

      Highlights

      • Weight loss surgery is an effective intervention for obesity and related disorders.
      • Roux-en-Y gastric bypass and sleeve gastrectomy are the most common surgeries.
      • Two recent trials suggest they are comparably safe and effective.
      • Novel therapies, including endoscopic interventions, are under active investigation.
      • Weight loss surgery is under-utilized; we should improve access and delivery.

      Abstract

      Weight loss surgery is the most effective intervention for addressing obesity and related metabolic disorders such as diabetes. We describe common surgical procedures as well as emerging and investigational procedures in terms of their capacity to induce weight reduction and their risk profiles. We then discuss the impact of weight loss surgery on important obesity related disorders including diabetes, cardiovascular disease, and non-alcoholic fatty liver disease. The question of operative choice is discussed with respect to benefits and risks of common procedures. Reoperative weight loss surgery, an increasingly common element of weight loss surgical practice, is reviewed. We briefly discuss the metabolic mechanism of action of weight loss surgery. Lack of access to and under-utilization of weight loss surgery represent important challenges to adequate obesity treatment, and we review these topics as well.

      Abbreviations:

      ASMBS (American Society for Metabolic and Bariatric Surgery), BMI (body mass index), CT (computed tomography), GB (gastric banding), GERD (gastroesophageal reflux disease), MBSAQIP (Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program), NAFLD (non-alcoholic fatty liver disease), NASH (non-alcoholic steatohepatitis), NSAID (non-steroidal anti-inflammatory drug), OSA (obstructive sleep apnea), SG (sleeve gastrectomy), RYGB (Roux-en-Y gastric bypass), VTE (venous thromboembolism), WLS (weight loss surgery)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Heymsfield S.B.
        • Wadden T.A.
        Mechanisms, pathophysiology, and management of obesity.
        N Engl J Med. 2017; 376 ([PMID:28099824]): 254-266https://doi.org/10.1056/NEJMra1514009
        • Kim D.D.
        • Basu A.
        Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis.
        Value Health. 2016; 19 ([PMID:27565277]): 602-613https://doi.org/10.1016/j.jval.2016.02.008
        • Hales C.M.
        • Fryar C.D.
        • Carroll M.D.
        • Freedman D.S.
        • Ogden C.L.
        Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016.
        JAMA. 2018; 319 ([PMID:29570750]): 1723-1725https://doi.org/10.1001/jama.2018.3060
        • Colquitt J.L.
        • Pickett K.
        • Loveman E.
        • Frampton G.K.
        Surgery for weight loss in adults.
        Cochrane Database Syst Rev. 2014; ([PMID:25105982])CD003641https://doi.org/10.1002/14651858.CD003641.pub4
        • Mechanick J.I.
        • Youdim A.
        • Jones D.B.
        • Timothy Garvey W.
        • Hurley D.L.
        • Molly McMahon M.
        • et al.
        Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.
        Surg Obes Relat Dis. 2013; 9 ([PMID:23537696]): 159-191https://doi.org/10.1016/j.soard.2012.12.010
        • Rubino F.
        • Nathan D.M.
        • Eckel R.H.
        • Schauer P.R.
        • Alberti K.G.M.M.
        • Zimmet P.Z.
        • et al.
        Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations.
        Surg Obes Relat Dis. 2016; 12: 1144-1162https://doi.org/10.1016/j.soard.2016.05.018
        • Courcoulas A.P.
        • King W.C.
        • Belle S.H.
        • Berk P.
        • Flum D.R.
        • Garcia L.
        • et al.
        Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study.
        JAMA Surg. 2018; 153 ([PMID:29214306]): 427-434https://doi.org/10.1001/jamasurg.2017.5025
        • Sjöström L.
        • Peltonen M.
        • Jacobson P.
        • Ahlin S.
        • Andersson-Assarsson J.
        • Anveden Å.
        • et al.
        Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.
        JAMA. 2014; 311: 2297https://doi.org/10.1001/jama.2014.5988
        • Schiavon C.A.
        • Bersch-Ferreira A.C.
        • Santucci E.V.
        • Oliveira J.D.
        • Torreglosa C.R.
        • Bueno P.T.
        • et al.
        Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension).
        Circulation. 2018; 137 ([PMID:29133606]): 1132-1142https://doi.org/10.1161/CIRCULATIONAHA.117.032130
        • Sjöström L.
        • Peltonen M.
        • Jacobson P.
        • Sjöström C.D.
        • Karason K.
        • Wedel H.
        • et al.
        Bariatric surgery and long-term cardiovascular events.
        JAMA. 2012; 307 ([PMID:22215166]): 56-65https://doi.org/10.1001/jama.2011.1914
        • Aggarwal R.
        • Harling L.
        • Efthimiou E.
        • Darzi A.
        • Athanasiou T.
        • Ashrafian H.
        The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes.
        Obes Surg. 2016; 26 ([PMID:26328532]): 1030-1040https://doi.org/10.1007/s11695-015-1866-5
        • Ashrafian H.
        • Toma T.
        • Rowland S.P.
        • Harling L.
        • Tan A.
        • Efthimiou E.
        • et al.
        Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses.
        Obes Surg. 2015; 25 ([PMID:25537297]): 1239-1250https://doi.org/10.1007/s11695-014-1533-2
        • Avgerinos K.I.
        • Spyrou N.
        • Mantzoros C.S.
        • Dalamaga M.
        Obesity and cancer risk: emerging biological mechanisms and perspectives.
        Metabolism. 2018; ([PMID:30445141])https://doi.org/10.1016/j.metabol.2018.11.001
        • López-Suárez A.
        Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors.
        Metabolism. 2018; ([PMID:30412695])https://doi.org/10.1016/j.metabol.2018.10.013
        • Schauer D.P.
        • Feigelson H.S.
        • Koebnick C.
        • Caan B.
        • Weinmann S.
        • Leonard A.C.
        • et al.
        Association between weight loss and the risk of cancer after bariatric surgery.
        Obesity (Silver Spring). 2017; 25 ([PMID:29086527]): S52-S57https://doi.org/10.1002/oby.22002
        • Sjöström L.
        • Gummesson A.
        • Sjöström C.D.
        • Narbro K.
        • Peltonen M.
        • Wedel H.
        • et al.
        Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial.
        Lancet Oncol. 2009; 10 ([PMID:19556163]): 653-662https://doi.org/10.1016/S1470-2045(09)70159-7
        • Reges O.
        • Greenland P.
        • Dicker D.
        • Leibowitz M.
        • Hoshen M.
        • Gofer I.
        • et al.
        Association of bariatric surgery using laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy vs usual care obesity management with all-cause mortality.
        JAMA. 2018; 319 ([PMID:29340677]): 279-290https://doi.org/10.1001/jama.2017.20513
        • Sjöström L.
        • Narbro K.
        • Sjöström C.D.
        • Karason K.
        • Larsson B.
        • Wedel H.
        • et al.
        Effects of bariatric surgery on mortality in Swedish obese subjects.
        N Engl J Med. 2007; 357 ([PMID:17715408]): 741-752https://doi.org/10.1056/NEJMoa066254
        • Adams T.D.
        • Gress R.E.
        • Smith S.C.
        • Halverson R.C.
        • Simper S.C.
        • Rosamond W.D.
        • et al.
        Long-term mortality after gastric bypass surgery.
        N Engl J Med. 2007; 357 ([PMID:17715409]): 753-761https://doi.org/10.1056/NEJMoa066603
        • Arterburn D.E.
        • Olsen M.K.
        • Smith V.A.
        • Livingston E.H.
        • Van Scoyoc L.
        • Yancy W.S.
        • et al.
        Association between bariatric surgery and long-term survival.
        JAMA. 2015; 313 ([PMID:25562267]): 62-70https://doi.org/10.1001/jama.2014.16968
        • Koh C.Y.
        • Inaba C.S.
        • Sujatha-Bhaskar S.
        • Hohmann S.
        • Ponce J.
        • Nguyen N.T.
        Laparoscopic adjustable gastric band explantation and implantation at academic centers.
        J Am Coll Surg. 2017; 225 ([PMID:28754410]): 532-537https://doi.org/10.1016/j.jamcollsurg.2017.06.015
        • Albaugh V.L.
        • Abumrad N.N.
        Surgical treatment of obesity.
        F1000Res. 2018; 7 ([PMID:29904577])https://doi.org/10.12688/f1000research.13515.1
        • Peterli R.
        • Wölnerhanssen B.K.
        • Peters T.
        • Vetter D.
        • Kröll D.
        • Borbély Y.
        • et al.
        Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial.
        JAMA. 2018; 319 ([PMID:29340679]): 255-265https://doi.org/10.1001/jama.2017.20897
        • Salminen P.
        • Helmiö M.
        • Ovaska J.
        • Juuti A.
        • Leivonen M.
        • Peromaa-Haavisto P.
        • et al.
        Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial.
        JAMA. 2018; 319 ([PMID:29340676]): 241-254https://doi.org/10.1001/jama.2017.20313
        • Kehagias I.
        • Karamanakos S.N.
        • Argentou M.
        • Kalfarentzos F.
        Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI <50 kg/m2.
        Obes Surg. 2011; 21 ([PMID:21818647]): 1650-1656https://doi.org/10.1007/s11695-011-0479-x
        • Puzziferri N.
        • Roshek T.B.
        • Mayo H.G.
        • Gallagher R.
        • Belle S.H.
        • Livingston E.H.
        Long-term follow-up after bariatric surgery: a systematic review.
        JAMA. 2014; 312 ([PMID:25182102]): 934-942https://doi.org/10.1001/jama.2014.10706
        • Courcoulas A.P.
        • Christian N.J.
        • Belle S.H.
        • Berk P.D.
        • Flum D.R.
        • Garcia L.
        • et al.
        Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity.
        JAMA. 2013; 310 ([PMID:24189773]): 2416-2425https://doi.org/10.1001/jama.2013.280928
        • Maciejewski M.L.
        • Arterburn D.E.
        • Van Scoyoc L.
        • Smith V.A.
        • Yancy W.S.
        • Weidenbacher H.J.
        • et al.
        Bariatric surgery and long-term durability of weight loss.
        JAMA Surg. 2016; 151: 1046https://doi.org/10.1001/jamasurg.2016.2317
        • O'Brien P.E.
        • MacDonald L.
        • Anderson M.
        • Brennan L.
        • Brown W.A.
        Long-term outcomes after bariatric surgery.
        Ann Surg. 2013; 257: 87-94https://doi.org/10.1097/sla.0b013e31827b6c02
        • Adams T.D.
        • Davidson L.E.
        • Litwin S.E.
        • Kim J.
        • Kolotkin R.L.
        • Nanjee M.N.
        • et al.
        Weight and metabolic outcomes 12 years after gastric bypass.
        N Engl J Med. 2017; 377 ([PMID:28930514]): 1143-1155https://doi.org/10.1056/NEJMoa1700459
        • Mitchell J.E.
        • Christian N.J.
        • Flum D.R.
        • Pomp A.
        • Pories W.J.
        • Wolfe B.M.
        • et al.
        Postoperative behavioral variables and weight change 3 years after bariatric surgery.
        JAMA Surg. 2016; 151 ([PMID:27096225]): 752-757https://doi.org/10.1001/jamasurg.2016.0395
        • Stenberg E.
        • Szabo E.
        • Agren G.
        • Näslund E.
        • Boman L.
        • Bylund A.
        • et al.
        Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry.
        Ann Surg. 2014; 260 ([PMID:24374541]): 1040-1047https://doi.org/10.1097/SLA.0000000000000431
        • Alizadeh R.F.
        • Li S.
        • Inaba C.
        • Penalosa P.
        • Hinojosa M.W.
        • Smith B.R.
        • et al.
        Risk factors for gastrointestinal leak after bariatric surgery: MBASQIP analysis.
        J Am Coll Surg. 2018; 227 ([PMID:29605723]): 135-141https://doi.org/10.1016/j.jamcollsurg.2018.03.030
        • Dang J.T.
        • Switzer N.
        • Delisle M.
        • Laffin M.
        • Gill R.
        • Birch D.W.
        • et al.
        Predicting venous thromboembolism following laparoscopic bariatric surgery: development of the BariClot tool using the MBSAQIP database.
        Surg Endosc. 2018; ([PMID:30003351])https://doi.org/10.1007/s00464-018-6348-0
        • American SFMABSCIC
        ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients.
        Surg Obes Relat Dis. 2013; 9 ([PMID:23769113]): 493-497https://doi.org/10.1016/j.soard.2013.03.006
        • Haskins I.N.
        • Ju T.
        • Whitlock A.E.
        • Rivas L.
        • Amdur R.L.
        • Lin P.P.
        • et al.
        Older age confers a higher risk of 30-day morbidity and mortality following laparoscopic bariatric surgery: an analysis of the metabolic and bariatric surgery quality improvement program.
        Obes Surg. 2018; ([PMID:29663253])https://doi.org/10.1007/s11695-018-3233-9
        • Inaba C.S.
        • Koh C.Y.
        • Sujatha-Bhaskar S.
        • Silva J.P.
        • Chen Y.
        • Nguyen D.V.
        • et al.
        One-year mortality after contemporary laparoscopic bariatric surgery: an analysis of the bariatric outcomes longitudinal database.
        J Am Coll Surg. 2018; 226 ([PMID:29551698]): 1166-1174https://doi.org/10.1016/j.jamcollsurg.2018.02.013
        • Sandvik J.
        • Hole T.
        • Klöckner C.A.
        • Kulseng B.E.
        • Wibe A.
        High-frequency of computer tomography and surgery for abdominal pain after Roux-en-Y gastric bypass.
        Obes Surg. 2018; ([PMID:29619755])https://doi.org/10.1007/s11695-018-3223-y
        • Mala T.
        • Høgestøl I.
        Abdominal pain after Roux-En-Y gastric bypass for morbid obesity.
        Scand J Surg. 2018; ([1457496918772360; PMID:29739280])https://doi.org/10.1177/1457496918772360
        • Coblijn U.K.
        • Goucham A.B.
        • Lagarde S.M.
        • Kuiken S.D.
        • van Wagensveld B.A.
        Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review.
        Obes Surg. 2014; 24 ([PMID:24234733]): 299-309https://doi.org/10.1007/s11695-013-1118-5
        • Coblijn U.K.
        • Lagarde S.M.
        • de Castro S.M.
        • Kuiken S.D.
        • van Wagensveld B.A.
        Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management.
        Obes Surg. 2015; 25 ([PMID:25381115]): 805-811https://doi.org/10.1007/s11695-014-1482-9
        • Geubbels N.
        • Lijftogt N.
        • Fiocco M.
        • van Leersum N.J.
        • Wouters M.W.
        • de Brauw L.M.
        Meta-analysis of internal herniation after gastric bypass surgery.
        Br J Surg. 2015; 102 ([PMID:25708572]): 451-460https://doi.org/10.1002/bjs.9738
        • Greenstein A.J.
        • O'Rourke R.W.
        Abdominal pain after gastric bypass: suspects and solutions.
        Am J Surg. 2011; 201 ([PMID:21333269]): 819-827https://doi.org/10.1016/j.amjsurg.2010.05.007
        • Al-Mansour M.R.
        • Mundy R.
        • Canoy J.M.
        • Dulaimy K.
        • Kuhn J.N.
        • Romanelli J.
        Internal hernia after laparoscopic antecolic Roux-en-Y gastric bypass.
        Obes Surg. 2015; 25 ([PMID:26037306]): 2106-2111https://doi.org/10.1007/s11695-015-1672-0
        • Spector D.
        • Perry Z.
        • Shah S.
        • Kim J.J.
        • Tarnoff M.E.
        • Shikora S.A.
        Roux-en-Y gastric bypass: hyperamylasemia is associated with small bowel obstruction.
        Surg Obes Relat Dis. 2015; 11 ([PMID:25264325]): 38-43https://doi.org/10.1016/j.soard.2014.04.030
        • Bal B.S.
        • Finelli F.C.
        • Shope T.R.
        • Koch T.R.
        Nutritional deficiencies after bariatric surgery.
        Nat Rev Endocrinol. 2012; 8: 544-556https://doi.org/10.1038/nrendo.2012.48
        • Weng T.C.
        • Chang C.H.
        • Dong Y.H.
        • Chang Y.C.
        • Chuang L.M.
        Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
        BMJ Open. 2015; 5 ([PMID:26185175])e006964https://doi.org/10.1136/bmjopen-2014-006964
        • Maghrabi A.H.
        • Wolski K.
        • Abood B.
        • Licata A.
        • Pothier C.
        • Bhatt D.L.
        • et al.
        Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy.
        Obesity (Silver Spring). 2015; 23 ([PMID:26193177]): 2344-2348https://doi.org/10.1002/oby.21150
        • Rodríguez-Carmona Y.
        • López-Alavez F.J.
        • González-Garay A.G.
        • Solís-Galicia C.
        • Meléndez G.
        • Serralde-Zúñiga A.E.
        Bone mineral density after bariatric surgery. A systematic review.
        Int J Surg. 2014; 12 ([PMID:25110331]): 976-982https://doi.org/10.1016/j.ijsu.2014.08.002
        • Chakhtoura M.T.
        • Nakhoul N.N.
        • Shawwa K.
        • Mantzoros C.
        • El Hajj Fuleihan G.A.
        Hypovitaminosis D in bariatric surgery: a systematic review of observational studies.
        Metabolism. 2016; 65: 574-585https://doi.org/10.1016/j.metabol.2015.12.004
        • Zhang Q.
        • Chen Y.
        • Li J.
        • Chen D.
        • Cheng Z.
        • Xu S.
        • et al.
        A meta-analysis of the effects of bariatric surgery on fracture risk.
        Obes Rev. 2018; 19 ([PMID:29334691]): 728-736https://doi.org/10.1111/obr.12665
        • Parrott J.
        • Frank L.
        • Rabena R.
        • Craggs-Dino L.
        • Isom K.A.
        • Greiman L.
        American Society for Metabolic and Bariatric Surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients.
        Surg Obes Relat Dis. 2017; 13 ([PMID:28392254]): 727-741https://doi.org/10.1016/j.soard.2016.12.018
        • Berg P.
        • McCallum R.
        Dumping syndrome: a review of the current concepts of pathophysiology, diagnosis, and treatment.
        Dig Dis Sci. 2016; 61: 11-18https://doi.org/10.1007/s10620-015-3839-x
        • Emous M.
        • Wolffenbuttel B.H.R.
        • van Dijk G.
        • Totté E.
        • van Beek A.P.
        Long-term self-reported symptom prevalence of early and late dumping in a patient population after sleeve gastrectomy, primary, and revisional gastric bypass surgery.
        Surg Obes Relat Dis. 2018; ([PMID:29858129])https://doi.org/10.1016/j.soard.2018.04.011
        • Nielsen J.B.
        • Pedersen A.M.
        • Gribsholt S.B.
        • Svensson E.
        • Richelsen B.
        Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass.
        Surg Obes Relat Dis. 2016; 12: 1562-1568https://doi.org/10.1016/j.soard.2016.04.017
        • Emous M.
        • Wolffenbuttel B.H.R.
        • Totté E.
        • van Beek A.P.
        The short- to mid-term symptom prevalence of dumping syndrome after primary gastric-bypass surgery and its impact on health-related quality of life.
        Surg Obes Relat Dis. 2017; 13 ([PMID:28624531]): 1489-1500https://doi.org/10.1016/j.soard.2017.04.028
        • Mulla C.M.
        • Middelbeek R.J.W.
        • Patti M.E.
        Mechanisms of weight loss and improved metabolism following bariatric surgery.
        Ann N Y Acad Sci. 2018; 1411 ([PMID:28868615]): 53-64https://doi.org/10.1111/nyas.13409
        • American SFMABSCIC
        Bariatric surgery procedures.
        2018 ([https://asmbs.org/patients/bariatric-surgery-procedures])
        • Wölnerhanssen B.
        • Peterli R.
        State of the art: sleeve gastrectomy.
        Dig Surg. 2014; 31 ([PMID:24819496]): 40-47https://doi.org/10.1159/000354320
        • Osland E.
        • Yunus R.M.
        • Khan S.
        • Memon B.
        • Memon M.A.
        Weight loss outcomes in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a meta-analysis and systematic review of randomized controlled trials.
        Surg Laparosc Endosc Percutan Tech. 2017; 27 ([PMID:28145963]): 8-18https://doi.org/10.1097/SLE.0000000000000374
        • Shoar S.
        • Saber A.A.
        Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies.
        Surg Obes Relat Dis. 2017; 13 ([PMID:27720197]): 170-180https://doi.org/10.1016/j.soard.2016.08.011
        • Vitiello A.
        • Pilone V.
        • Ferraro L.
        • Forestieri P.
        Is the sleeve gastrectomy always a better procedure? Five-year results from a retrospective matched case-control study.
        Obes Surg. 2018; ([PMID:29549660])https://doi.org/10.1007/s11695-018-3161-8
        • Berger E.R.
        • Clements R.H.
        • Morton J.M.
        • Huffman K.M.
        • Wolfe B.M.
        • Nguyen N.T.
        • et al.
        The impact of different surgical techniques on outcomes in laparoscopic sleeve gastrectomies: the first report from the metabolic and bariatric surgery accreditation and quality improvement program (MBSAQIP).
        Ann Surg. 2016; 264 ([PMID:27433904]): 464-473https://doi.org/10.1097/SLA.0000000000001851
        • Dhar V.K.
        • Hanseman D.J.
        • Watkins B.M.
        • Paquette I.M.
        • Shah S.A.
        • Thompson J.R.
        What matters after sleeve gastrectomy: patient characteristics or surgical technique.
        Surgery. 2018; 163 ([PMID:29398036]): 571-577https://doi.org/10.1016/j.surg.2017.09.052
        • Valli P.V.
        • Gubler C.
        Review article including treatment algorithm: endoscopic treatment of luminal complications after bariatric surgery.
        Clin Obes. 2017; 7 ([PMID:28199050]): 115-122https://doi.org/10.1111/cob.12182
        • Ben-Porat T.
        • Elazary R.
        • Goldenshluger A.
        • Sherf Dagan S.
        • Mintz Y.
        • Weiss R.
        Nutritional deficiencies four years after laparoscopic sleeve gastrectomy-are supplements required for a lifetime.
        Surg Obes Relat Dis. 2017; 13 ([PMID:28416186]): 1138-1144https://doi.org/10.1016/j.soard.2017.02.021
        • Ali M.
        • El Chaar M.
        • Ghiassi S.
        • Rogers A.M.
        • American SFMABSCIC
        American Society for Metabolic and Bariatric Surgery updated position statement on sleeve gastrectomy as a bariatric procedure.
        Surg Obes Relat Dis. 2017; 13 ([PMID:29054173]): 1652-1657https://doi.org/10.1016/j.soard.2017.08.007
        • Dixon J.B.
        • O'Brien P.E.
        • Playfair J.
        • Chapman L.
        • Schachter L.M.
        • Skinner S.
        • et al.
        Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.
        JAMA. 2008; 299 ([PMID:18212316]): 316-323https://doi.org/10.1001/jama.299.3.316
        • Ibrahim A.M.
        • Thumma J.R.
        • Dimick J.B.
        Reoperation and Medicare expenditures after laparoscopic gastric band surgery.
        JAMA Surg. 2017; 152 ([PMID:28514487]): 835-842https://doi.org/10.1001/jamasurg.2017.1093
        • Spaniolas K.
        • Kasten K.R.
        • Brinkley J.
        • Sippey M.E.
        • Mozer A.
        • Chapman W.H.
        • et al.
        The changing bariatric surgery landscape in the USA.
        Obes Surg. 2015; 25 ([PMID:26072171]): 1544-1546https://doi.org/10.1007/s11695-015-1764-x
        • Nguyen N.T.
        • Kim E.
        • Vu S.
        • Phelan M.
        Ten-year outcomes of a prospective randomized trial of laparoscopic gastric bypass versus laparoscopic gastric banding.
        Ann Surg. 2018; 268 ([PMID:28692476]): 106-113https://doi.org/10.1097/SLA.0000000000002348
        • Arterburn D.
        • Powers J.D.
        • Toh S.
        • Polsky S.
        • Butler M.G.
        • Portz J.D.
        • et al.
        Comparative effectiveness of laparoscopic adjustable gastric banding vs laparoscopic gastric bypass.
        JAMA Surg. 2014; 149 ([PMID:25353723]): 1279-1287https://doi.org/10.1001/jamasurg.2014.1674
        • Sharples A.J.
        • Charalampakis V.
        • Daskalakis M.
        • Tahrani A.A.
        • Singhal R.
        Systematic review and meta-analysis of outcomes after revisional bariatric surgery following a failed adjustable gastric band.
        Obes Surg. 2017; 27 ([PMID:28477245]): 2522-2536https://doi.org/10.1007/s11695-017-2677-7
        • Papasavas P.
        • El Chaar M.
        • Kothari S.N.
        American Society for Metabolic and Bariatric Surgery position statement on vagal blocking therapy for obesity.
        Surg Obes Relat Dis. 2016; 12: 460-461https://doi.org/10.1016/j.soard.2015.12.004
        • Apovian C.M.
        • Shah S.N.
        • Wolfe B.M.
        • Ikramuddin S.
        • Miller C.J.
        • Tweden K.S.
        • et al.
        Two-year outcomes of vagal nerve blocking (vBloc) for the treatment of obesity in the ReCharge trial.
        Obes Surg. 2017; 27 ([PMID:27506803]): 169-176https://doi.org/10.1007/s11695-016-2325-7
        • Sarr M.G.
        • Billington C.J.
        • Brancatisano R.
        • Brancatisano A.
        • Toouli J.
        • Kow L.
        • et al.
        The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity.
        Obes Surg. 2012; 22 ([PMID:22956251]): 1771-1782https://doi.org/10.1007/s11695-012-0751-8
        • Shikora S.A.
        • Toouli J.
        • Herrera M.F.
        • Kulseng B.
        • Brancatisano R.
        • Kow L.
        • et al.
        Intermittent vagal nerve block for improvements in obesity, cardiovascular risk factors, and glycemic control in patients with type 2 diabetes mellitus: 2-year results of the VBLOC DM2 study.
        Obes Surg. 2016; 26: 1021-1028https://doi.org/10.1007/s11695-015-1914-1
        • Marceau P.
        • Biron S.
        • Marceau S.
        • Hould F.-S.
        • Lebel S.
        • Lescelleur O.
        • et al.
        Long-term metabolic outcomes 5 to 20 years after biliopancreatic diversion.
        Obes Surg. 2015; 25: 1584-1593https://doi.org/10.1007/s11695-015-1599-5
        • Risstad H.
        • Søvik T.T.
        • Engström M.
        • Aasheim E.T.
        • Fagerland M.W.
        • Olsén M.F.
        • et al.
        Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial.
        JAMA Surg. 2015; 150 ([PMID:25650964]): 352-361https://doi.org/10.1001/jamasurg.2014.3579
        • Committee CI
        ASMBS policy statement on gastric plication.
        Surg Obes Relat Dis. 2011; 7 ([PMID:21621164]): 262https://doi.org/10.1016/j.soard.2011.03.004
        • Barrichello S.
        • Minata M.K.
        • García Ruiz de Gordejuela A.
        • Bernardo W.M.
        • de Souza T.F.
        • Galvão Neto M.
        • et al.
        Laparoscopic greater curvature plication and laparoscopic sleeve gastrectomy treatments for obesity: systematic review and meta-analysis of short- and mid-term results.
        Obes Surg. 2018; ([PMID:29951784])https://doi.org/10.1007/s11695-018-3330-9
        • Jirapinyo P.
        • Thompson C.C.
        Endoscopic bariatric and metabolic therapies: surgical analogues and mechanisms of action.
        Clin Gastroenterol Hepatol. 2017; 15 ([PMID:27989851]): 619-630https://doi.org/10.1016/j.cgh.2016.10.021
        • Rohde U.
        • Hedbäck N.
        • Gluud L.L.
        • Vilsbøll T.
        • Knop F.K.
        Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis.
        Diabetes Obes Metab. 2016; 18 ([PMID:26537317]): 300-305https://doi.org/10.1111/dom.12603
        • Betzel B.
        • Drenth J.P.H.
        • Siersema P.D.
        Adverse events of the duodenal-jejunal bypass liner: a systematic review.
        Obes Surg. 2018; ([PMID:30121857])https://doi.org/10.1007/s11695-018-3441-3
        • Armijo P.R.
        • Pagkratis S.
        • Boilesen E.
        • Tanner T.
        • Oleynikov D.
        Growth in robotic-assisted procedures is from conversion of laparoscopic procedures and not from open surgeons' conversion: a study of trends and costs.
        Surg Endosc. 2018; 32 ([PMID:29067582]): 2106-2113https://doi.org/10.1007/s00464-017-5908-z
        • Magouliotis D.E.
        • Tasiopoulou V.S.
        • Sioka E.
        • Zacharoulis D.
        Robotic versus laparoscopic sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis.
        Obes Surg. 2017; 27 ([PMID:27815863]): 245-253https://doi.org/10.1007/s11695-016-2444-1
        • Sharma G.
        • Strong A.T.
        • Tu C.
        • Brethauer S.A.
        • Schauer P.R.
        • Aminian A.
        Robotic platform for gastric bypass is associated with more resource utilization: an analysis of MBSAQIP dataset.
        Surg Obes Relat Dis. 2018; 14 ([PMID:29276076]): 304-310https://doi.org/10.1016/j.soard.2017.11.018
        • Stefanidis D.
        • Bailey S.B.
        • Kuwada T.
        • Simms C.
        • Gersin K.
        Robotic gastric bypass may lead to fewer complications compared with laparoscopy.
        Surg Endosc. 2018; 32 ([PMID:28726145]): 610-616https://doi.org/10.1007/s00464-017-5710-y
        • Gleysteen J.J.
        A history of intragastric balloons.
        Surg Obes Relat Dis. 2016; 12 ([PMID:26775045]): 430-435https://doi.org/10.1016/j.soard.2015.10.074
        • Tate C.M.
        • Geliebter A.
        Intragastric balloon treatment for obesity: review of recent studies.
        Adv Ther. 2017; 34 ([PMID:28707286]): 1859-1875https://doi.org/10.1007/s12325-017-0562-3
        • Tate C.M.
        • Geliebter A.
        Intragastric balloon treatment for obesity: FDA safety updates.
        Adv Ther. 2018; 35 ([PMID:29285708]): 1-4https://doi.org/10.1007/s12325-017-0647-z
        • Mingrone G.
        • Panunzi S.
        • De Gaetano A.
        • Guidone C.
        • Iaconelli A.
        • Nanni G.
        • et al.
        Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
        Lancet. 2015; 386 ([PMID:26369473]): 964-973https://doi.org/10.1016/S0140-6736(15)00075-6
        • Simonson D.C.
        • Halperin F.
        • Foster K.
        • Vernon A.
        • Goldfine A.B.
        Clinical and patient-centered outcomes in obese patients with type 2 diabetes 3 years after randomization to Roux-en-Y gastric bypass surgery versus intensive lifestyle management: the SLIMM-T2D study.
        Diabetes Care. 2018; 41 ([PMID:29432125]): 670-679https://doi.org/10.2337/dc17-0487
        • Ikramuddin S.
        • Korner J.
        • Lee W.J.
        • Connett J.E.
        • Inabnet W.B.
        • Billington C.J.
        • et al.
        Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.
        JAMA. 2013; 309 ([PMID:23736733]): 2240-2249https://doi.org/10.1001/jama.2013.5835
        • Ikramuddin S.
        • Korner J.
        • Lee W.J.
        • Bantle J.P.
        • Thomas A.J.
        • Connett J.E.
        • et al.
        Durability of addition of Roux-en-Y gastric bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: a randomized control trial.
        Diabetes Care. 2016; 39 ([PMID:27311493]): 1510-1518https://doi.org/10.2337/dc15-2481
        • Ikramuddin S.
        • Korner J.
        • Lee W.J.
        • Thomas A.J.
        • Connett J.E.
        • Bantle J.P.
        • et al.
        Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study.
        JAMA. 2018; 319 ([PMID:29340678]): 266-278https://doi.org/10.1001/jama.2017.20813
        • Schauer P.R.
        • Bhatt D.L.
        • Kirwan J.P.
        • Wolski K.
        • Aminian A.
        • Brethauer S.A.
        • et al.
        Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes.
        N Engl J Med. 2017; 376: 641-651https://doi.org/10.1056/nejmoa1600869
        • Aminian A.
        • Brethauer S.A.
        • Andalib A.
        • Punchai S.
        • Mackey J.
        • Rodriguez J.
        • et al.
        Can sleeve gastrectomy “cure” diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes.
        Ann Surg. 2016; 264 ([PMID:27433906]): 674-681https://doi.org/10.1097/SLA.0000000000001857
        • Carlsson L.M.S.
        • Sjöholm K.
        • Karlsson C.
        • Jacobson P.
        • Andersson-Assarsson J.C.
        • Svensson P.-A.
        • et al.
        Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.
        Lancet Diabetes Endocrinol. 2017; 5: 271-279https://doi.org/10.1016/s2213-8587(17)30061-x
        • O'Brien R.
        • Johnson E.
        • Haneuse S.
        • Coleman K.J.
        • O'Connor P.J.
        • Fisher D.P.
        • et al.
        Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care: a matched cohort study.
        Ann Intern Med. 2018; ([PMID:30083761])https://doi.org/10.7326/M17-2383
        • Aftab H.
        • Risstad H.
        • Søvik T.T.
        • Bernklev T.
        • Hewitt S.
        • Kristinsson J.A.
        • et al.
        Five-year outcome after gastric bypass for morbid obesity in a Norwegian cohort.
        Surg Obes Relat Dis. 2014; 10 ([PMID:24182445]): 71-78https://doi.org/10.1016/j.soard.2013.05.003
        • Heneghan H.M.
        • Huang H.
        • Kashyap S.R.
        • Gornik H.L.
        • McCullough A.J.
        • Schauer P.R.
        • et al.
        Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio.
        Surg Obes Relat Dis. 2013; 9 ([PMID:22264909]): 100-107https://doi.org/10.1016/j.soard.2011.11.018
        • Kligman M.D.
        • Dexter D.J.
        • Omer S.
        • Park A.E.
        Shrinking cardiovascular risk through bariatric surgery: application of Framingham risk score in gastric bypass.
        Surgery. 2008; 143 ([PMID:18374051]): 533-538https://doi.org/10.1016/j.surg.2007.10.021
        • Mor A.
        • Omotosho P.
        • Torquati A.
        Cardiovascular risk in obese diabetic patients is significantly reduced one year after gastric bypass compared to one year of diabetes support and education.
        Surg Endosc. 2014; 28 ([PMID:24853843]): 2815-2820https://doi.org/10.1007/s00464-014-3550-6
        • Priester T.
        • Ault T.G.
        • Davidson L.
        • Gress R.
        • Adams T.D.
        • Hunt S.C.
        • et al.
        Coronary calcium scores 6 years after bariatric surgery.
        Obes Surg. 2015; 25 ([PMID:24927692]): 90-96https://doi.org/10.1007/s11695-014-1327-6
        • Sundström J.
        • Bruze G.
        • Ottosson J.
        • Marcus C.
        • Näslund I.
        • Neovius M.
        Weight loss and heart failure: a nationwide study of gastric bypass surgery versus intensive lifestyle treatment.
        Circulation. 2017; 135 ([PMID:28258170]): 1577-1585https://doi.org/10.1161/CIRCULATIONAHA.116.025629
        • Benotti P.N.
        • Wood G.C.
        • Carey D.J.
        • Mehra V.C.
        • Mirshahi T.
        • Lent M.R.
        • et al.
        Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure.
        J Am Heart Assoc. 2017; 6 ([PMID:28536154])https://doi.org/10.1161/JAHA.116.005126
        • Persson C.E.
        • Björck L.
        • Lagergren J.
        • Lappas G.
        • Giang K.W.
        • Rosengren A.
        Risk of heart failure in obese patients with and without bariatric surgery in Sweden-a registry-based study.
        J Card Fail. 2017; 23 ([PMID:28506731]): 530-537https://doi.org/10.1016/j.cardfail.2017.05.005
        • Marchesi F.
        • Giacosa R.
        • Reggiani V.
        • De Sario G.
        • Tartamella F.
        • Melani E.
        • et al.
        Morphological changes in the carotid artery intima after gastric bypass for morbid obesity.
        Obes Surg. 2017; 27 ([PMID:27389676]): 357-363https://doi.org/10.1007/s11695-016-2279-9
        • Jamaly S.
        • Carlsson L.
        • Peltonen M.
        • Jacobson P.
        • Sjöström L.
        • Karason K.
        Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects.
        J Am Coll Cardiol. 2016; 68 ([PMID:27931605]): 2497-2504https://doi.org/10.1016/j.jacc.2016.09.940
        • Bower G.
        • Toma T.
        • Harling L.
        • Jiao L.R.
        • Efthimiou E.
        • Darzi A.
        • et al.
        Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology.
        Obes Surg. 2015; 25 ([PMID:25917981]): 2280-2289https://doi.org/10.1007/s11695-015-1691-x
        • Lassailly G.
        • Caiazzo R.
        • Buob D.
        • Pigeyre M.
        • Verkindt H.
        • Labreuche J.
        • et al.
        Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients.
        Gastroenterology. 2015; 149 ([quiz e15; PMID:25917783]): 379-388https://doi.org/10.1053/j.gastro.2015.04.014
        • Luo R.B.
        • Suzuki T.
        • Hooker J.C.
        • Covarrubias Y.
        • Schlein A.
        • Liu S.
        • et al.
        How bariatric surgery affects liver volume and fat density in NAFLD patients.
        Surg Endosc. 2018; 32 ([PMID:29218660]): 1675-1682https://doi.org/10.1007/s00464-017-5846-9
        • Arterburn D.
        • Gupta A.
        Comparing the outcomes of sleeve gastrectomy and Roux-en-Y gastric bypass for severe obesity.
        JAMA. 2018; 319 ([PMID:29340659]): 235-237https://doi.org/10.1001/jama.2017.20449
        • Osland E.
        • Yunus R.M.
        • Khan S.
        • Alodat T.
        • Memon B.
        • Memon M.A.
        Postoperative early major and minor complications in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a meta-analysis and systematic review.
        Obes Surg. 2016; 26 ([PMID:26894908]): 2273-2284https://doi.org/10.1007/s11695-016-2101-8
        • Zhang Y.
        • Ju W.
        • Sun X.
        • Cao Z.
        • Xinsheng X.
        • Daquan L.
        • et al.
        Laparoscopic sleeve gastrectomy versus laparoscopic Roux-En-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies.
        Obes Surg. 2015; 25: 19-26https://doi.org/10.1007/s11695-014-1385-9
        • Young M.T.
        • Gebhart A.
        • Phelan M.J.
        • Nguyen N.T.
        Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP.
        J Am Coll Surg. 2015; 220 ([PMID:25907869]): 880-885https://doi.org/10.1016/j.jamcollsurg.2015.01.059
        • Brethauer S.A.
        • Kothari S.
        • Sudan R.
        • Williams B.
        • English W.J.
        • Brengman M.
        • et al.
        Systematic review on reoperative bariatric surgery: American Society for Metabolic and Bariatric Surgery Revision Task Force.
        Surg Obes Relat Dis. 2014; 10 ([PMID:24776071]): 952-972https://doi.org/10.1016/j.soard.2014.02.014
        • Mann J.P.
        • Jakes A.D.
        • Hayden J.D.
        • Barth J.H.
        Systematic review of definitions of failure in revisional bariatric surgery.
        Obes Surg. 2015; 25 ([PMID:25515500]): 571-574https://doi.org/10.1007/s11695-014-1541-2
        • Nedelcu M.
        • Khwaja H.A.
        • Rogula T.G.
        Weight regain after bariatric surgery-how should it be defined.
        Surg Obes Relat Dis. 2016; 12 ([PMID:27350180]): 1129-1130https://doi.org/10.1016/j.soard.2016.04.028
        • Mahawar K.K.
        • Nimeri A.
        • Adamo M.
        • Borg C.M.
        • Singhal R.
        • Khan O.
        • et al.
        Practices concerning revisional bariatric surgery: a survey of 460 surgeons.
        Obes Surg. 2018; ([PMID:29616464])https://doi.org/10.1007/s11695-018-3226-8
        • Tran D.D.
        • Nwokeabia I.D.
        • Purnell S.
        • Zafar S.N.
        • Ortega G.
        • Hughes K.
        • et al.
        Revision of Roux-En-Y gastric bypass for weight regain: a systematic review of techniques and outcomes.
        Obes Surg. 2016; 26 ([PMID:27138603]): 1627-1634https://doi.org/10.1007/s11695-016-2201-5
        • Abu Dayyeh B.K.
        • Lautz D.B.
        • Thompson C.C.
        Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass.
        Clin Gastroenterol Hepatol. 2011; 9 ([PMID:21092760]): 228-233https://doi.org/10.1016/j.cgh.2010.11.004
        • Heneghan H.M.
        • Yimcharoen P.
        • Brethauer S.A.
        • Kroh M.
        • Chand B.
        Influence of pouch and stoma size on weight loss after gastric bypass.
        Surg Obes Relat Dis. 2012; 8: 408-415https://doi.org/10.1016/j.soard.2011.09.010
        • Brunaldi V.O.
        • Jirapinyo P.
        • de Moura D.T.H.
        • Okazaki O.
        • Bernardo W.M.
        • Galvão Neto M.
        • et al.
        Endoscopic treatment of weight regain following Roux-en-Y gastric bypass: a systematic review and meta-analysis.
        Obes Surg. 2018; 28 ([PMID:29082456]): 266-276https://doi.org/10.1007/s11695-017-2986-x
        • Borbély Y.
        • Winkler C.
        • Kröll D.
        • Nett P.
        Pouch reshaping for significant weight regain after Roux-en-Y gastric bypass.
        Obes Surg. 2017; 27 ([PMID:27510586]): 439-444https://doi.org/10.1007/s11695-016-2329-3
        • Elbahrawy A.
        • Bougie A.
        • Albader M.
        • Aggarwal R.
        • Demyttenaere S.
        • Andalib A.
        • et al.
        Laparoscopic wedge resection of gastrojejunostomy for weight recidivism after gastric bypass.
        Obes Surg. 2017; 27 ([PMID:28470487]): 2829-2835https://doi.org/10.1007/s11695-017-2706-6
        • Cheung D.
        • Switzer N.J.
        • Gill R.S.
        • Shi X.
        • Karmali S.
        Revisional bariatric surgery following failed primary laparoscopic sleeve gastrectomy: a systematic review.
        Obes Surg. 2014; 24 ([PMID:24927693]): 1757-1763https://doi.org/10.1007/s11695-014-1332-9
        • Dijkhorst P.J.
        • Boerboom A.B.
        • Janssen I.M.C.
        • Swank D.J.
        • Wiezer R.M.J.
        • Hazebroek E.J.
        • et al.
        Failed sleeve gastrectomy: single anastomosis duodenoileal bypass or Roux-en-Y gastric bypass? A multicenter cohort study.
        Obes Surg. 2018; https://doi.org/10.1007/s11695-018-3429-z
        • Weiner J.P.
        • Goodwin S.M.
        • Chang H.Y.
        • Bolen S.D.
        • Richards T.M.
        • Johns R.A.
        • et al.
        Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data.
        JAMA Surg. 2013; 148 ([PMID:23426865]): 555-562https://doi.org/10.1001/jamasurg.2013.1504
        • Alsumali A.
        • Eguale T.
        • Bairdain S.
        • Samnaliev M.
        Cost-effectiveness analysis of bariatric surgery for morbid obesity.
        Obes Surg. 2018; ([PMID:29335933])https://doi.org/10.1007/s11695-017-3100-0
        • Kim D.D.
        • Arterburn D.E.
        • Sullivan S.D.
        • Basu A.
        Economic value of greater access to bariatric procedures for patients with severe obesity and diabetes.
        Med Care. 2018; 56: 583-588https://doi.org/10.1097/mlr.0000000000000924
        • Kim D.D.
        • Arterburn D.E.
        • Sullivan S.D.
        • Basu A.
        Association between the publication of clinical evidence and the use of bariatric surgery.
        Obes Surg. 2018; 28 ([PMID:29086183]): 1321-1328https://doi.org/10.1007/s11695-017-2990-1
        • Henkel D.S.
        • Mora-Pinzon M.
        • Remington P.L.
        • Jolles S.A.
        • Voils C.I.
        • Gould J.C.
        • et al.
        Trends in the prevalence of severe obesity and bariatric surgery access: a state-level analysis from 2011 to 2014.
        J Laparoendosc Adv Surg Tech A. 2017; 27 ([PMID:28557643]): 669-675https://doi.org/10.1089/lap.2017.0157
        • Macht R.
        • Rosen A.
        • Horn G.
        • Carmine B.
        • Hess D.
        An exploration of system-level factors and the geographic variation in bariatric surgery utilization.
        Obes Surg. 2016; 26 ([PMID:27034061]): 1635-1638https://doi.org/10.1007/s11695-016-2164-6
        • Hennings D.L.
        • Baimas-George M.
        • Al-Quarayshi Z.
        • Moore R.
        • Kandil E.
        • DuCoin C.G.
        The inequity of bariatric surgery: publicly insured patients undergo lower rates of bariatric surgery with worse outcomes.
        Obes Surg. 2018; 28: 44-51https://doi.org/10.1007/s11695-017-2784-5
        • Zhang L.
        • Scott J.
        • Shi L.
        • Truong K.
        • Hu Q.
        • Ewing J.A.
        • et al.
        Changes in utilization and peri-operative outcomes of bariatric surgery in large U.S. hospital database, 2011–2014.
        PLoS One. 2017; 12 ([PMID:29053709])e0186306https://doi.org/10.1371/journal.pone.0186306
        • Birkmeyer N.J.
        • Gu N.
        Race, socioeconomic status, and the use of bariatric surgery in Michigan.
        Obes Surg. 2012; 22 ([PMID:20559894]): 259-265https://doi.org/10.1007/s11695-010-0210-3
        • Stanford F.C.
        • Jones D.B.
        • Schneider B.E.
        • Blackburn G.L.
        • Apovian C.M.
        • Hess D.T.
        • et al.
        Patient race and the likelihood of undergoing bariatric surgery among patients seeking surgery.
        Surg Endosc. 2015; 29 ([PMID:25492453]): 2794-2799https://doi.org/10.1007/s00464-014-4014-8
        • Imbus J.R.
        • Voils C.I.
        • Funk L.M.
        Bariatric surgery barriers: a review using Andersen's model of health services use.
        Surg Obes Relat Dis. 2018; 14 ([PMID:29249585]): 404-412https://doi.org/10.1016/j.soard.2017.11.012
        • Funk L.M.
        • Jolles S.A.
        • Greenberg C.C.
        • Schwarze M.L.
        • Safdar N.
        • McVay M.A.
        • et al.
        Primary care physician decision making regarding severe obesity treatment and bariatric surgery: a qualitative study.
        Surg Obes Relat Dis. 2016; 12 ([PMID:26948943]): 893-901https://doi.org/10.1016/j.soard.2015.11.028
        • Funk L.M.
        • Jolles S.
        • Fischer L.E.
        • Voils C.I.
        Patient and referring practitioner characteristics associated with the likelihood of undergoing bariatric surgery.
        JAMA Surg. 2015; 150: 999https://doi.org/10.1001/jamasurg.2015.1250
        • Simon R.
        • Lahiri S.W.
        Provider practice habits and barriers to care in obesity management in a large multicenter health system.
        Endocr Pract. 2018; 24 ([PMID:29561192]): 321-328https://doi.org/10.4158/EP-2017-0221
        • Pilitsi E.
        • Farr O.M.
        • Polyzos S.A.
        • Perakakis N.
        • Nolen-Doerr E.
        • Papathanasiou A.E.
        • et al.
        Pharmacotherapy of obesity: available medications and drugs under investigation.
        Metabolism. 2018; ([PMID:30391259])https://doi.org/10.1016/j.metabol.2018.10.010